CNS Services
Sponsors and CROs continue to face extreme challenges and high risks in the design and execution of clinical trials in support of new CNS therapies. WCG has built a global cohort of expert clinicians, proprietary cognitive assessments, targeted interventions, and supporting technology to reduce the risk of trial failure for the most complex and subjective indications.
Sponsors and CROs continue to face extreme challenges and high risks in the design and execution of clinical trials in support of new CNS therapies. The likelihood of a clinical success is narrow, and the variability of data generated in the study only exacerbates the challenges.
To improve signal detection and reduce the risk of inconclusive results, sponsors and CROs need a capable and trusted partner that leads with science first. WCG has built a global cohort of expert clinicians, proprietary cognitive assessments, targeted interventions, and supporting technology to reduce the risk of trial failure for the most complex and subjective indications, including: Alzheimer’s Disease, Parkinson’s Disease, Depression, Schizophrenia, Pain and Painful Disorders, Movement Disorders, Multiple Sclerosis, and Epilepsy. Contact our team of CNS experts today to get started.